MedeAnalytics, Inc., an Emeryville, CA-based provider of cloud-based financial performance analytics for the healthcare industry, received a majority investment from private equity firm Thoma Bravo, LLC.
The amount of the transaction was not disclosed. Prior investors Bain Capital Integral Investors LLC and Emergence Capital Partners will remain minority shareholders.
The company will use the proceeds from the investment to continue growing organically and through strategic acquisitions.
Led by Andy Hurd, chief executive officer, MedeAnalytics provides an evidence-based analytics platform that allows healthcare providers to leverage the vast amounts of data available to deliver care and to improve their financial health.
Its cloud-based tools are used by over 1500 healthcare organizations across the United States and United Kingdom.